{"id":1038125,"date":"2021-02-15T03:13:32","date_gmt":"2021-02-15T08:13:32","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/is-prothena-corporation-plc-prta-a-winner-in-the-biotechnology-industry-investorsobserver\/"},"modified":"2024-08-17T16:14:12","modified_gmt":"2024-08-17T20:14:12","slug":"is-prothena-corporation-plc-prta-a-winner-in-the-biotechnology-industry-investorsobserver","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-prothena-corporation-plc-prta-a-winner-in-the-biotechnology-industry-investorsobserver.php","title":{"rendered":"Is Prothena Corporation PLC (PRTA) a Winner in the Biotechnology Industry? &#8211; InvestorsObserver"},"content":{"rendered":"<p><p>A rating of 88 puts Prothena Corporation PLC (PRTA) near the top of the Biotechnology industry according to InvestorsObserver. Prothena Corporation PLC's score of 88 means it scores higher than 88% of stocks in the industry. Prothena Corporation PLC also received an overall rating of 73, putting it above 73% of all stocks. Biotechnology is ranked 16 out of the 148 industries.<\/p>\n<p>Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks.<\/p>\n<p>These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.<\/p>\n<p>Prothena Corporation PLC (PRTA) stock has gained 16.88% while the S&P 500 is down 0% as of 10:19 AM on Friday, Feb 12. PRTA is up $2.65 from the previous closing price of $15.70 on volume of 238,634 shares. Over the past year the S&P 500 has risen 16.07% while PRTA is up 42.03%. PRTA lost -$2.78 per share the over the last 12 months. <\/p>\n<p>Click Here to get the full Stock Score Report on Prothena Corporation PLC (PRTA) Stock.<\/p>\n<p>Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.<\/p>\n<p>You May Also Like<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.investorsobserver.com\/news\/stock-update\/is-prothena-corporation-plc-prta-a-winner-in-the-biotechnology-industry\" title=\"Is Prothena Corporation PLC (PRTA) a Winner in the Biotechnology Industry? - InvestorsObserver\" rel=\"noopener noreferrer\">Is Prothena Corporation PLC (PRTA) a Winner in the Biotechnology Industry? - InvestorsObserver<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A rating of 88 puts Prothena Corporation PLC (PRTA) near the top of the Biotechnology industry according to InvestorsObserver. Prothena Corporation PLC's score of 88 means it scores higher than 88% of stocks in the industry.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/is-prothena-corporation-plc-prta-a-winner-in-the-biotechnology-industry-investorsobserver.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1038125","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038125"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1038125"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1038125\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1038125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1038125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1038125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}